| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174501A1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 01/23/2002 | EP1174439A2 Compositions and methods for treating infections using analogues of indolicidin |
| 01/23/2002 | EP1173619A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 01/23/2002 | EP1173602A1 Ecotin derivatives |
| 01/23/2002 | EP1173598A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
| 01/23/2002 | EP1173596A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 01/23/2002 | EP1173595A1 Use of coxsackie viruses for improving cell transfection |
| 01/23/2002 | EP1173593A2 Gcn4-derived expression of heterologous coding sequences and different uses thereof |
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173589A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/23/2002 | EP1173578A2 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| 01/23/2002 | EP1173577A2 Prevention, diagnosis and treatment of lyme disease |
| 01/23/2002 | EP1173576A1 A strain suitable for producing a live, orally applicable escherichia coli vaccine for the prevention of postweaning diarrhoea in pigs, and the procedure suitable for producing that strain |
| 01/23/2002 | EP1173575A2 Maize npr1 polynucleotides and methods of use |
| 01/23/2002 | EP1173574A1 Splicing factor |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173572A2 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173570A2 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173567A2 Tribonectins |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173564A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173551A2 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/23/2002 | EP1173546A1 A (bacillus) protein production cell |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173483A1 Acrp30r1m, a homolog of acrp30 |
| 01/23/2002 | EP1173482A1 Insulin crystals for pulmonary administration |
| 01/23/2002 | EP1173481A1 Inactivated cytokines for immunisation |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173476A1 Soybean protein nutraceuticals |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173474A1 Membrane disruptive peptides covalently oligomerized |
| 01/23/2002 | EP1173470A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173467A1 Chemokine-derived synthetic peptides |
| 01/23/2002 | EP1173466A1 Method of inhibiting leukocyte adhesion to fibrinogen |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173457A1 Polynucleotide and polypeptide sequences encoding human organic anion transporter 6(hoatp6) and screening methods thereof |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1173199A1 RAS ONCOGEN p21 PEPTIDE VACCINES |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173194A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 01/23/2002 | EP1173191A1 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP1017789A4 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 01/23/2002 | EP1015478A4 Library screening as a strategy to clone drugs for g protein coupled receptors |
| 01/23/2002 | EP0938564B1 Disease resistance in vitis |
| 01/23/2002 | EP0884947A4 Dna vaccination for induction of suppressive t cell response |
| 01/23/2002 | EP0877602B1 Process for the production of powdered pulmonary surfactant preparations |
| 01/23/2002 | EP0797590B1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/23/2002 | EP0796269B1 Filtration method for removing viruses from virus-contaminated aqueous solutions |
| 01/23/2002 | EP0784421B1 Pest trap plants and crop protection |
| 01/23/2002 | EP0745093B1 New oligopeptides with affinity to opioid receptors |
| 01/23/2002 | EP0704056B9 Leukocyte adhesion assay |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | EP0623144B1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332802A Production of recombinant monellin using methylotrophic yeast expression system |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332800A Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 01/23/2002 | CN1332797A Bleaching enzymes and detergent compositions comprising them |
| 01/23/2002 | CN1332750A Modified treponema pallidum outer membrane protein, its immunoassay use and immunoassay kit |
| 01/23/2002 | CN1332749A HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332239A Hepatitis B virus complete-genome polymerase chimera and its construction process and application |
| 01/23/2002 | CN1332176A Semi-dry microwave synthesis process of phosphoprotein |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/22/2002 | US6340748 A high level promoter derived from tomato; for genetic engineering, for large scale expression in tomato fruit |
| 01/22/2002 | US6340743 Antibody ligands for specific binding to stalk of polymeric immunoglobulin receptor of cell with proviso that ligand does not bind to secretory component of receptor |
| 01/22/2002 | US6340742 Erythropoietin conjugates |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340669 Lipoprotein complexes and compositions containing them |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | US6340667 Contacting the bacteria or fungi with a bacterial of fungal cell killing effective amount of a fragment of reptilian hemoglobin protein, selected from reptilian heme-free hemoglobin .alpha. chain, a reptilia heme-free hemoglobin |
| 01/22/2002 | US6340593 Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kDa pesticidal proteins |
| 01/22/2002 | US6340591 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 01/22/2002 | US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340576 Nucleic acid molecules related to card-4L and CARD-4S |
| 01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
| 01/22/2002 | US6340564 A polynucleotide encoding a polypeptide for screening antibiotics of streptococci infection; therapy for otitis media, conjunctivitis, pneumonia, bacteremia, meninigitis, respiratory disorders and endocarditis |
| 01/22/2002 | US6340463 For the production of both polyclonal and monoclonal antibodies to defined antigenic domains |
| 01/22/2002 | US6340462 For inducing immunological response in a vertebrate to pathogen by inoculating with synthetic recombinant avipox virus modified by presence, in non-essential region of avipox genome, of dna from any source which encodes for antigen |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2149333C Eck receptor ligands |